C. Dupont, R. Rudigoz, M. Cortet, S. Touzet, C. Colin et al., Incidence, étiologies et facteurs de risque de l'hémorragie du post-partum : étude en population dans 106 maternités Françaises [3] Bouvier-Colle MH, Saucedo M, Deneux-Tharaux C. L'enquête confidentielle française sur les morts maternelles : quelles conséquences pour les soins en obstétrique Hémorragie du post-partum : fréquence, conséquences en termes de santé et facteurs de risque avant l'accouchement Type and location of placenta previa affect preterm delivery risk related to antepartum hemorrhage, J Gynecol Obstet Biol Reprod J Gynecol Obstet Biol Reprod J Gynecol Obstet Biol Reprod Int J Med Sci, vol.4033510, issue.2812, pp.87-1024, 1996.

G. Garmi and R. Salim, Epidemiology, Etiology, Diagnosis, and Management of Placenta Accreta, Obstetrics and Gynecology International, vol.176, issue.6, p.873929, 2012.
DOI : 10.1016/j.ijoa.2007.11.010

. Cesarine, Evaluation des taux de césarienne, 2013.

W. Prendiville, D. Elbourne, and S. Mcdonald, Active versus expectant management in the third stage of labour, Cochrane Database Syst Rev, issue.3, p.7, 2000.

C. Deneux-tharaux, L. Sentilhes, F. Maillard, E. Closset, D. Vardon et al., Effect of routine controlled cord traction as part of the active management of the third stage of labour on postpartum haemorrhage: multicentre randomised controlled trial (TRACOR), BMJ, vol.346, issue.mar28 4, p.1541, 2013.
DOI : 10.1136/bmj.f1541

URL : https://hal.archives-ouvertes.fr/inserm-00809184

M. Dreyfus, G. Beucher, M. A. Langer, and B. , Prise en charge obst??tricale initiale en cas d???h??morragie du post-partum, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.33, issue.8, 2004.
DOI : 10.1016/S0368-2315(04)96647-1

P. Dolley, Etats des lieux et aspects évolutifs de la chirurgie pour l'hémorragie du postpartum en Basse-Normandie, Thèse de Doctorat, 2011.

H. Shakur, D. Elbourne, M. Gulmezoglu, Z. Alfirevic, C. Ronsmans et al., The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial, Trials, vol.25, issue.7, p.40, 2010.
DOI : 10.1038/bjc.1977.1

N. Novikova and G. Hofmeyr, Tranexamic acid for preventing postpartum haemorrhage, Cochrane Database Syst Rev, vol.2010, issue.7, p.7872

P. Ferrer, I. Roberts, E. Sydenham, K. Blackhall, and H. Shakur, Anti-fibrinolytic agents in post partum haemorrhage: a systematic review, BMC Pregnancy and Childbirth, vol.14, issue.3, p.29, 2009.
DOI : 10.1136/jcp.s3-14.1.41

A. Ducloy-bouthors, B. Jude, A. Duhamel, F. Broisin, C. Huissoud et al., High-dose tranexamic acid reduces blood loss in postpartum haemorrhage, Critical Care, vol.15, issue.2, p.117, 2011.
DOI : 10.1186/1745-6215-11-40

P. Raynal, . Le, and . De-bakri, Le ballonnet de Bakri, Gyn??cologie Obst??trique & Fertilit??, vol.39, issue.7-8, pp.438-479, 2011.
DOI : 10.1016/j.gyobfe.2011.04.001

S. Gross, Rôle des prostaglandines E2 dans l'hémostase Artérielle et l'Arthérothrombose [thèse de Doctorat, 2006.

J. Fabre, M. Nguyen, K. Athirakul, K. Coggins, J. Mcneish et al., Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation, Journal of Clinical Investigation, vol.107, issue.5, pp.603-613, 2001.
DOI : 10.1172/JCI10881

H. Ma, A. Hara, C. Xiao, Y. Okada, O. Takahata et al., Increased bleeding tendency and decreased susceptibility to thromboembolism in mice lacking the prostaglandin E receptor subtype EP(3). Circulation, pp.1176-80, 2001.

B. Langer, E. Boudier, R. Haberstich, and M. Dreyfus, Prise en charge obst??tricale en cas d???h??morragie du post-partum qui persiste malgr?? les mesures initiales ou qui est grave d???embl??e, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.33, issue.8, pp.4-73, 2004.
DOI : 10.1016/S0368-2315(04)96649-5

J. Blum, B. Winikoff, S. Raghavan, R. Dabash, M. Ramadan et al., Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial, The Lancet, vol.375, issue.9710, pp.217-240, 2010.
DOI : 10.1016/S0140-6736(09)61923-1

M. Widmer, J. Blum, G. Hofmeyr, G. Carroli, H. Abdel-aleem et al., Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial, The Lancet, vol.375, issue.9728, pp.1808-1821, 2010.
DOI : 10.1016/S0140-6736(10)60348-0

®. Nalador, in : VIDAL Le dictionnaire. 86ème éd. Paris: Edition du Vidal, p.1396

F. Goffinet, B. Haddad, B. Carbonne, E. Sebban, E. Papiernik et al., Utilisation pratique du sulprostone dans le traitementdes hémorragies de la délivrance, J Gynecol Obstet Biol Reprod (Paris), vol.24, issue.2, pp.209-225, 1995.

C. Tharaux, Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity, Obstet Gynecol, vol.117, issue.1, pp.21-31, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00574137

T. Schmitz, K. Tararbit, C. Dupont, R. Rudigoz, M. Bouvier-colle et al., Prostaglandin E2 Analogue Sulprostone for Treatment of Atonic Postpartum Hemorrhage, Obstetrics & Gynecology, vol.118, issue.2, Part 1, pp.257-65, 2011.
DOI : 10.1097/AOG.0b013e3182255335

C. Combs, E. Murphy, R. Laros, and J. , Factors associated with postpartum hemorrhage with vaginal birth, Obstet Gynecol, vol.77, issue.1, pp.69-76, 1991.

P. Lefevre, S. Brucato, A. Mayaud, R. Morello, C. Deneux-tharaux et al., ??valuation de la mise en place d???une prise en charge r??gionale des h??morragies du postpartum par un audit des cas graves??: ??tude avant-apr??s (2002???2005), Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.38, issue.3, pp.209-228, 2002.
DOI : 10.1016/j.jgyn.2009.03.010

I. Al-zirqi, S. Vangen, L. Forsen, and B. Stray-pedersen, Prevalence and risk factors of severe obstetric haemorrhage, BJOG: An International Journal of Obstetrics & Gynaecology, vol.21, issue.10, pp.1265-72, 2008.
DOI : 10.1111/j.1471-0528.2008.01859.x

. Orphanet, Maladie de Von Wilbrand, 2014.

M. Jolly, N. Sebire, J. Harris, L. Regan, and S. Robinson, Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.111, issue.1, pp.9-14, 2003.
DOI : 10.1016/S0301-2115(03)00154-4

C. Combs, E. Murphy, R. Laros, and J. , Factors Associated Cesarean with Hemorrhage in Deliveries, Obstetrical & Gynecological Survey, vol.46, issue.6, pp.77-82, 1991.
DOI : 10.1097/00006254-199106000-00011

C. Onwere, I. Gurol-urganci, D. Cromwell, T. Mahmood, A. Templeton et al., Maternal morbidity associated with placenta praevia among women who had elective caesarean section, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.159, issue.1, pp.62-68, 2011.
DOI : 10.1016/j.ejogrb.2011.07.008

P. Van-den-berg, S. Schmidt, J. Gesche, and E. Saling, Fetal distress and the condition of the newborn using cardiotocography and fetal blood analysis during labour, BJOG: An International Journal of Obstetrics and Gynaecology, vol.135, issue.1, pp.72-77, 1987.
DOI : 10.1016/S0140-6736(82)91462-3

C. Tharaux, Induction of labor and risk of postpartum hemorrhage in low risk parturients, PLoS One, vol.8, issue.1, p.54858, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00802974

J. Belghiti, G. Kayem, C. Dupont, R. Rudigoz, M. Bouvier-colle et al., Oxytocin during labour and risk of severe postpartum haemorrhage: a population-based, cohort-nested case-control study, BMJ Open, vol.1, issue.2, p.514, 2011.
DOI : 10.1136/bmjopen-2011-000514

R. Hayashi, M. Castillo, and M. Noah, Management of severe postpartum hemorrhage with a prostaglandin F2 alpha analogue, Obstet Gynecol, vol.63, issue.6, pp.806-814, 1984.

V. Tessier and F. Pierre, Facteurs de risques au cours du travail et prévention clinique et pharmacologique, J Gynecol Obstet Biol Reprod, vol.33, pp.4-29, 2004.
DOI : 10.1016/s0368-2315(04)96646-x